BRIEF published on 10/28/2025 at 17:55, 9 months 13 days ago FUTRUE ajuste la rémunération en espèces pour le retrait forcé de PharmaSGP Assemblée Générale Squeeze-out Compensation En Espèces PharmaSGP Futrue GmbH
BRIEF published on 10/28/2025 at 17:55, 9 months 13 days ago FUTRUE Adjusts Cash Compensation for PharmaSGP Squeeze-Out General Meeting Squeeze-out Cash Compensation PharmaSGP Futrue GmbH
PRESS RELEASE published on 10/28/2025 at 17:50, 9 months 13 days ago FUTRUE increases adequate cash compensation under the squeeze-out FUTRUE increases adequate cash compensation under squeeze-out for PharmaSGP Holding SE minority shareholders. Cash compensation raised to EUR 30.64 per share effective immediately Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE FUTRUE
BRIEF published on 09/22/2025 at 15:20, 10 months 18 days ago PharmaSGP Calls Extraordinary General Meeting for Squeeze-out Decision General Meeting Squeeze-out Share Transfer PharmaSGP Futrue GmbH
BRIEF published on 09/22/2025 at 15:20, 10 months 18 days ago PharmaSGP convoque une assemblée générale extraordinaire pour prendre une décision de retrait obligatoire Assemblée Générale Transfert D'actions PharmaSGP Retrait Forcé Futrue GmbH
PRESS RELEASE published on 09/22/2025 at 15:15, 10 months 18 days ago PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out PharmaSGP Holding SE convenes an extraordinary general meeting to resolve on squeeze-out of remaining shareholders. Cash compensation specified at EUR 29.33 per share Extraordinary General Meeting Squeeze-out Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 09/11/2025 at 09:05, 10 months 29 days ago PharmaSGP Releases Preliminary Half-Year Figures for 2025 Adjusted EBITDA Germany PharmaSGP OTC Pharmaceuticals 2025 Revenues
BRIEF published on 09/11/2025 at 09:05, 10 months 29 days ago PharmaSGP publie ses chiffres préliminaires du premier semestre 2025 Allemagne EBITDA Ajusté PharmaSGP Chiffre D'affaires 2025 Médicaments En Vente Libre
PRESS RELEASE published on 09/11/2025 at 09:00, 10 months 29 days ago PharmaSGP publishes preliminary half-year figures for 2025 PharmaSGP Holding SE releases preliminary half-year figures for 2025, showing a 13.0% revenue increase. Adjusted EBITDA declined slightly due to higher expenses. Forecast aims for continued growth amidst global uncertainties Adjusted EBITDA Revenue Increase Growth Forecast PharmaSGP Half-Year Figures
BRIEF published on 08/06/2025 at 16:21, 1 year ago PharmaSGP annonce sa radiation de la Bourse de Francfort Bourse Bourse De Francfort Radiation PharmaSGP Futrue GmbH
Published on 08/11/2026 at 00:40, 5 hours 39 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 5 hours 54 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 6 hours 44 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 6 hours 49 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 6 hours 54 minutes ago Ur-Energy Reports Second Quarter 2026 Results
Published on 08/10/2026 at 22:15, 8 hours 4 minutes ago Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 8 hours 14 minutes ago Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 9 hours 55 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 10 hours 44 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 11 hours 19 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Published on 08/10/2026 at 18:00, 12 hours 19 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 12 hours 19 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 12 hours 34 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 18 hours 25 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
